Serum is taken from each melanoma patient at every follow up after signed concent. With
ELISA the marker MIA is evaluated. An increase of MIA serum level will lead to search for
metastasis by oncologists.
Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Longitudinal, Time Perspective: Prospective
Ulrich C Schaller, MD
University of Munich, Germany
Germany: Federal Institute for Drugs and Medical Devices